Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles

Journal:

Clinical Infectious Diseases

Published:

2026-01-14

DOI:

10.1093/cid/ciag023

Affiliations:

4

Authors:

17

Go to article

Institutions	Authors	Share
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain	6.916667	0.41
University of Barcelona (UB), Spain	5.916667	0.35
Biomedical Research Networking Center for Infectious Diseases (CIBERINFEC), Spain	3.916667	0.23
Reial Academia de Medicina de Catalunya (RAMC), Spain	0.250000	0.01

Interested in Medical Microbiology?